Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria?

Diabetic Medicine

Volumn 24, Issue 2, 2007, Pages 131-136

  Dunger, D B ^a,i   Schwarze, C P ^a   Cooper, J D ^b   Widmer, B ^a   Neil, H A W ^c   Shield, J ^d   Edge, J A ^e   Jones, T W ^f   Daneman, D ^g   Dalton, R N ^h  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adolescence; Intervention; Microalbuminuria; ORPS; Prediction

Indexed keywords

ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PHENOTYPE; PROGNOSIS; PROTEINURIA; REGRESSION ANALYSIS; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL MODEL; URINALYSIS; URINARY EXCRETION;

ADOLESCENT; ALBUMINURIA; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; PUBERTY; RISK FACTORS;

EID: 33846594873     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.02047.x     Document Type: Article

References (46)

1. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89-93.
2. Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T. The predictive value of microalbuminuria in IDDM. A 5-year follow-up study. Diabetes Care 1994; 17: 120-125.
3. Parving HH, Oxenboll B, Svensden PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982; 100: 550-555.
4. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 1984; 26: 406-410.
5. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. Br Med J 2004; 328: 1105.
6. Microalbuminuria Collaborative Study Group UK. Intensive therapy and progression to clinical albuminuria in patients with insulin-dependent diabetes and microalbuminuria. Br Med J 1995; 311: 373-377.
7. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003; 348: 2285-2293.
8. Viberti GC, Jarrett RJ, Keen H, Finkelstein DM, Warram JH, Krolewski AS. Microalbuminuria as prediction of nephropathy in diabetics. Lancet 1982; 2: 611.
9. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28: 590-596.
10. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10-year observational follow-up study. Br Med J 1996; 313: 779-784.
11. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360.
12. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a 23-year follow-up study. Kidney Int 1992; 41: 836-839.
13. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-35.
14. Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURO-DIAB Prospective Complications Study. Diabetologia 2004; 47: 1020-1028.
15. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al. Low-grade albuminuria and incidence of cardiovascular disease events in non-hypertensive and non-diabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975.
16. Wood D, Wray R, Poulter N, Williams B, Kirby M, Patel V et al. Joint British societies: guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl. V): V1-V52.
17. Gilbert RE, Tsalamandris C, Bach LA, Panagiotopoulos S, O'Brien RC, Allen TJ et al. Long-term glycaemic control and the rate of progression of early diabetic kidney disease. Kidney Int 1993; 44: 855-859.
18. ISPAD. Consensus Guidelines for the Management of Insulin-Dependent Diabetes in Childhood and Adolescence, 2000. Available from: www.d4pro.com/diabetesguidelines/index.htm?3 (accessed 5 December 2006).
19. Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA et al. for the Oxford Regional Prospective Study Group. Microalbuminuria prevalence varies with age, sex and puberty in children with insulin-dependent mellitus followed in a longitudinal study from diagnosis. Diabetes Care 1999; 22: 495-502.
20. Olsen BS, Sjolie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB et al. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complications 2004; 18: 160-164.
21. Amin R, Turner C, van Aken S, Bahu TK, Watts A, Lindsell DR et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int 2005; 68: 1740-1749.
22. Schultz CJ, Neil HA, Dalton RN, Dunger DB for the Oxford Regional Prospective Study Group. Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type I diabetes. Diabetes Care 2000; 23: 1811-1815.
23. Dahlquist G, Rudberg S. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand 1987; 76: 795-800.
24. Barkai L, Vamosi I, Lukacs K. Enhanced progression of urinary albumin excretion in IDDM during puberty. Diabetes Care 1998; 21: 1019-1023.
25. Couper JJ, Clarke CF, Byrne GC, Jones TW, Donaghue KC, Nairn J et al. Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus. Diabet Med 1997; 14: 766-771.
26. Drummond K, Mauer M and International Diabetic Nephropathy Study Group. The early natural history of nephropathy in type 1 diabetes. II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51: 1580-1587.
27. Walker JD, Close CF, Jones SL, Rafftery M, Keen H, Viberti G et al. Glomerular structure in type I (insulin-dependent) diabetic patients with normal and microalbuminuria. Kidney Int 1992; 41: 741-748.
28. Berg UB, Torbjornsdotter TB, Jaremko G, Thalme B. Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 1998; 9: 1047-1056.
29. Daniels SR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 2004; 145: 452-457.
30. Rosner E, Hennekens CH, Kais EH, Miall WE. Age-specific correlation analysis of longitudinal blood pressure data. Am J Epidemiol 1977; 106: 306-313.
31. Foulkes MA, David CE. An index of tracking for longitudinal data. Biometrics 1981; 37: 439-446.
32. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Am Med Assoc 2003; 290: 2159-2167.
33. ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type I diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001; 134: 370-379.
34. O'Hare P, Bilbous R, Mitchell T, O'Callaghan CJ, Viberti GC. ACE-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care 2000; 23: 1823-1829.
35. Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW. Angiotensin-converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 1990; 117: 39-45.
36. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type I (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990; 33: 470-476.
37. Yuksel H, Darcan S, Kabasakal C, Cura A, Mir S, Mavi E. Effect of enalapril on proteinuria, phosphaturia, and calciuria in insulin-dependent diabetes. Pediatr Nephrol 1998; 12: 648-650.
38. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453-473.
39. Rudberg S, Stattin EL, Dahlquist G. Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients. Diabetes 1998; 47: 1121-1126.
40. Rogers DG, White NH, Shalwitz RA, Palmberg P, Smith ME, Santiago JV. The effect of puberty on the development of early diabetic microvascular disease in insulin-dependent diabetes. Diabetes Res Clin Pract 1987; 3: 39-44.
41. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes: the Linköping Diabetes Complications Study. Diabetologia 2004; 47: 1266-1272.
42. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ et al. and the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
43. The National Paediatric Diabetes Audit. Results from the Audit Year 2002. Diabetes UK (in collaboration with the Royal College of Nursing, Royal College of Paediatrics and Child Health, and the British Society of Paediatric Endocrinology and Diabetes), London, 2004. Available from http://bsped.org.uk/ professional/diabetesuk/NationalPaediatricAudit.pdf
44. Holl RW, Swift PG, Mortensen HB, Lynggaard H, Hougaard P, Aanstoot HJ et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore Study Group. Eur J Pediatr 2003; 162: 22-29.
45. Dunger DB. Diabetes in puberty. Arch Dis Child 1992; 67: 569-570.
46. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV and the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001; 139: 804-812.